Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Societal CDMO, Inc. announced a key new customer project utilizing its automated fill/finish line and lyophilization unit at the company’s San Diego facility.
read more
DFE Pharma, a global leader in pharma-, biopharma-and nutraceutical excipient solutions, has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team. DFE Pharma, headquartered in Goch, Germany, ...
read more
Abzena Selects IPS for Turnkey Delivery of Their New CGMP Facility in North Carolina
IPS-Integrated Project Services, LLC, a provider of engineering, procurement, construction management, and validation (EPCMV) services, announces its support to ...
read more
Societal CDMO, Inc. has been selected by AmyriAD Pharma to provide CDMO services to support the ongoing clinical development of AD101. The compound, a novel T-type calcium channel modulator, is currently in clinical development for the treatment of ...
read more
Lonza has enhanced its offering for customers in the early phases of their clinical trials by adding a dedicated Early Phase Clinical Manufacturing facility at its Small Molecules site in Bend, Oregon.
read more
Veranova, formerly known as Johnson Matthey Health, has launched as an independent company following the acquisition by Altaris Capital Partners, LLC from Johnson Matthey PLC.
Veranova is a global contract development and manufacturing organization ...
read more
uMotif announced a new investment of $25.5m from a fund managed by Athyrium Capital Management, LP, the New York-based investment firm. The new funding will support continued scale up of uMotif's unique patient-first software platform for clinical ...
read more
EUROAPI has expanded its collaboration with Sanofi under the umbrella of their Master Agreement for Development and GMP Manufacturing Services (the “DSA”), dated October 1, 2021, to support Sanofi’s mRNA vaccine platform with the development of lipid...
read more
Jubilant Pharmova Limited has announced that Jubilant Pharma Limited, a wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, Jubilant HollisterStier LLC, (JHS) a leading US-based pharmaceutical contract manufacturer ...
read more
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. and its affiliates, has reached an agreement with the Attorney General of West Virginia that settles the state’s and its subdivisions opioid-related claims.
read more
International Process Plants (IPP) announced its subsidiary Humber Industrials Ltd. has reached an agreement to purchase Novartis UK's 170-acre active pharmaceutical ingredient (API) manufacturing plant site and assets in Grimsby, UK.
read more
Eurofins Discovery announced the formation of its new Scientific Advisory Board (SAB). Company officials gathered renowned leaders from the pharmaceutical and biotechnology industries to gain strategic insights to address the unmet needs in drug ...
read more
Piramal Pharma Limited's Pharma Solutions business announced that a new active pharmaceutical ingredient (API) plant at the company's site in Aurora, Ontario, has come online and successfully completed its initial production runs.
read more
Societal CDMO, Inc. unveiled the company’s new “20/80 Second Source Technical Transfer” service model. This new CDMO offering is designed to provide pharmaceutical companies with a time- and cost-efficient preparedness strategy for mitigating supply ...
read more
CoreRx, Inc., an industry-leading CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael, California announces Michael Grass, Ph.D. has joined CoreRx as Senior Director of Product ...
read more